PATENT CLAIM ANALYSIS

Application Number: 15894087
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "279000"]

Abstract:
Methods for treating and/or delaying onset of dysplastic lesions in the bronchial airway of an individual comprise delivering to the respiratory track of the individual an inhalable dry powder composition including an effective amount of myo-inositol.

Claim (Index 9):
The method of  claim 1 , wherein the dry powder composition includes one or more surfactants selected from the group consisting of palmitic acid, stearic acid, Tween 20, Tween 80, and Pluronic F68.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13642878', '13518504', '14438582', '13828337', '13837653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7363392656565244
- 35 USC 102 Novelty (BERT): 0.5315086895277774
- Combined Prediction Score: 0.7158562080436498
- Mean Citation Score: 191.593252
- Max Citation Score: 359.26984
- Similarity Product: 234.9660244557619

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test